Intervention
Droxidopa
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
13 shownEffects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureNCT02897063 · 2016-09-01
RECRUITINGSafety and Efficacy of Droxidopa for Fatigue in Patients With ParkinsonismNCT03446807 · 2021-12-01
WITHDRAWNBrain Perfusion & Oxygenation in Parkinson's Disease With NOHNCT03229174 · 2018-08-23
COMPLETEDEffect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)NCT03567447 · 2018-08-17
UNKNOWNNorepinephrine-targeted Therapy for Action Control in Parkinson DiseaseNCT03115827 · 2017-04-18
COMPLETEDStudy to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's DiseaseNCT02066571 · 2015-03-01
UNKNOWNA Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyNCT01927055 · 2013-11-01
TERMINATEDDroxidopa / Pyridostigmine in Orthostatic HypotensionNCT01370512 · 2011-11-01
ENROLLING_BY_INVITATIONA Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseNCT01176240 · 2010-06-01
COMPLETEDA Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaNCT00782340 · 2008-09-01
COMPLETEDClinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)NCT00633880 · 2008-01-01
COMPLETEDOpen-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)NCT00738062 · 2008-01-01
COMPLETEDAugmenting Effects of L-DOPS With Carbidopa and EntacaponeNCT00547911 · 2007-10-01
TERMINATEDCommon conditions
Parkinson Disease6Dopamine Beta Hydroxylase Deficiency4Multiple System Atrophy4Orthostatic Hypotension3Parkinson's Disease3Neurogenic Orthostatic Hypotension2Non-diabetic Neuropathy2Primary Autonomic Failure2Pure Autonomic Failure2Symptomatic Neurogenic Orthostatic Hypotension (NOH)2Autonomic Failure1Autonomic Nervous System Diseases1Cognitive Ability, General1Falls Patient1Freezing of Gait1Multiple Systems Atrophy1Non-Diabetic Autonomic Neuropathy1Progressive Supranuclear Palsy1Symptomatic Neurogenic Orthostatic Hypotension1
Leading sponsors
Trial status mix
COMPLETED6
TERMINATED2
UNKNOWN2
ENROLLING_BY_INVITATION1
RECRUITING1
WITHDRAWN1
Phase mix
PHASE25
PHASE35
PHASE12
PHASE42
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.